Rapidemic Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Private

  • Employees
  • 10

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 5

Rapidemic General Information

Description

Developer of molecular point-of-care test kits intended to diagnose infectious diseases on the spot. The company's kits utilize a primer technology to detect new airborne infectious diseases and speed up the testing of roaming viruses, enabling clinicians to test infected people anywhere without a laboratory and limited medical facilities and get the results within an hour after the test has been taken.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Langegracht 70
  • 2312 NV Leiden
  • Netherlands
+31 0474
Primary Industry
Diagnostic Equipment
Other Industries
Medical Supplies
Decision/Risk Analysis
Vertical(s)
LOHAS & Wellness, Digital Health, HealthTech
Corporate Office
  • Langegracht 70
  • 2312 NV Leiden
  • Netherlands
+31 0474

Rapidemic Timeline

2021202220232024
Date FoundedFinancing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Rapidemic Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Accelerator/Incubator 07-Feb-2024 Completed Generating Revenue
3. Accelerator/Incubator 01-Aug-2023 Completed Generating Revenue
2. Grant 30-Sep-2022 $19.8K $84.8K Completed Generating Revenue
1. Seed Round 13-Dec-2021 $84.8K $84.8K Completed Generating Revenue
To view Rapidemic’s complete valuation and funding history, request access »

Rapidemic Executive Team (4)

Name Title Board Seat
Violette Defourt Co-Founder, Chief Executive Officer & Business Developer
Lucy Chong Co-Founder
Peter Rahfeld Chief Operating Officer & Science & Operations Officer
You’re viewing 3 of 4 executive team members. Get the full list »

Rapidemic Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Rapidemic Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
unlock_ Accelerator/Incubator
BioInnovation Institute Accelerator/Incubator
Province Holland Zuid Government
Rijksdienst voor Ondernemend Nederland Government
Graduate Entrepreneur Venture Capital Minority
To view Rapidemic’s complete investors history, request access »

Rapidemic FAQs

  • When was Rapidemic founded?

    Rapidemic was founded in 2020.

  • Who is the founder of Rapidemic?

    Violette Defourt, Lucy Chong, and Eugene Golov are the founders of Rapidemic.

  • Who is the CEO of Rapidemic?

    Violette Defourt is the CEO of Rapidemic.

  • Where is Rapidemic headquartered?

    Rapidemic is headquartered in Leiden, Netherlands.

  • What is the size of Rapidemic?

    Rapidemic has 10 total employees.

  • What industry is Rapidemic in?

    Rapidemic’s primary industry is Diagnostic Equipment.

  • Is Rapidemic a private or public company?

    Rapidemic is a Private company.

  • What is Rapidemic’s current revenue?

    The current revenue for Rapidemic is .

  • How much funding has Rapidemic raised over time?

    Rapidemic has raised $84.8K.

  • Who are Rapidemic’s investors?

    unlock_, BioInnovation Institute, Province Holland Zuid, Rijksdienst voor Ondernemend Nederland, and Graduate Entrepreneur have invested in Rapidemic.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »